
LINK . SPRINGER . COM {
}
Title:
Novel dual-targeting c-Myc inhibitor D347-2761 represses myeloma growth via blocking c-Myc/Max heterodimerization and disturbing its stability | Cell Communication and Signaling
Description:
Background Transcription factor c-Myc plays a critical role in various physiological and pathological events. c-Myc gene rearrangement is closely associated with multiple myeloma (MM) progression and drug resistance. Thereby, targeting c-Myc is expected to be a useful therapeutic strategy for hematological disease, especially in MM. Methods Molecular docking-based virtual screening and dual-luciferase reporter gene assay were used to identify novel c-Myc inhibitors. Cell viability and flow cytometry were performed for evaluating myeloma cytotoxicity. Western blot, immunofluorescence, immunoprecipitation, GST pull down and Electrophoretic Mobility Shift Assay were performed for protein expression and interaction between c-Myc and Max. c-Myc downstream targets were measured by Q-PCR and Chromatin immunoprecipitation methods. Animal experiments were used to detect myeloma xenograft and infiltration in vivo. Results We successfully identified a novel c-Myc inhibitor D347-2761, which hindered the formation of c-Myc/Max heterodimer and disturbed c-Myc protein stability simultaneously. Compound D347-2761 dose-and time-dependently inhibited myeloma cell proliferation and induced apoptosis. Dual knockout Bak/Bax partially restored D347-2761-mediated cell death. Additionally, compound D347-2761 could, in combination with bortezomib (BTZ), enhance MM cell DNA damage and overcome BTZ drug resistance. Our in vivo studies also showed that compound D347-2761 repressed myeloma growth and distal infiltration by downregulating c-Myc expression. Mechanistically, novel dual-targeting c-Myc inhibitor D347-2761 promoted c-Myc protein degradation via stimulating c-Myc Thr58 phosphorylation levels, which ultimately led to transcriptional repression of CDK4 promoter activity. Conclusions We identified a novel dual-targeting c-Myc small molecular inhibitor D347-2761. And this study may provide a solid foundation for developing a novel therapeutic agent targeting c-Myc. Video Abstract
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {๐}
- Science
- Education
- Health & Fitness
Content Management System {๐}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {๐}
What is the average monthly size of link.springer.com audience?
๐ Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {๐ธ}
We can't figure out the monetization strategy.
Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might be making money, but it's not detectable how they're doing it.
Keywords {๐}
cmyc, cells, cell, article, myeloma, compound, fig, rpmi, google, scholar, assay, expression, protein, cas, analysis, treated, inhibitor, btz, apoptosis, cmycmax, dna, additional, group, molecular, treatment, file, stability, western, ncih, multiple, blot, damage, cdk, binding, dose, gene, drug, max, studies, showed, transcriptional, tumor, phosphorylation, target, china, control, figure, screening, results, degradation,
Topics {โ๏ธ}
2ย ฮผg p3flag-cmv-9-c-myc plasmids annexin v-apc/7-aad assay p3flag-cmv-9-myc plasmid pan-caspase inhibitor z-vad-fmk block c-myc/max heterodimerization targeting c-myc/max interaction blocking c-myc/max heterodimerization flag-tagged c-myc plasmids c-myc/max heterodimers bound c-myc response elements c-myc/max heterodimer significantly c-myc/max interaction domain c-myc unstable domain destroy c-myc/max interaction c-myc/max complex binding c-myc/max mutants obtained f-box protein fbw7 c-myc inhibitory activity proteasome-mediated protein degradation c-myc protein half-life c-myc/max complex interface dna double-strand breaks potential c-myc inhibitor c-myc transcriptional target disturb c-myc stability c-myc-mediated oncogenesis purchased commercial gst-c-myc c-myc thr58 promoted exogenous flag-c-myc c-myc inhibitor d347-2761 c-myc protein stability c-myc/max heterodimerization c-myc gene rearrangement c-myc protein instability c-myc/max complex c-myc binding sites e-box motif proto-oncogenic transcription factors c-mycโmediated physiological time-dependently inhibited rpmi-8226 targeting c-myc myc-max oncoprotein complex transcription factor c-myc c-myc promoter activity structure-based virtual screening c-myc downstream targets c-myc/max heterodimer phosphorylate c-myc thr58 pim kinase-dependent inhibition p-c-myc ser62
Schema {๐บ๏ธ}
WebPage:
mainEntity:
headline:Novel dual-targeting c-Myc inhibitor D347-2761 represses myeloma growth via blocking c-Myc/Max heterodimerization and disturbing its stability
description:Transcription factor c-Myc plays a critical role in various physiological and pathological events. c-Myc gene rearrangement is closely associated with multiple myeloma (MM) progression and drug resistance. Thereby, targeting c-Myc is expected to be a useful therapeutic strategy for hematological disease, especially in MM.
Molecular docking-based virtual screening and dual-luciferase reporter gene assay were used to identify novel c-Myc inhibitors. Cell viability and flow cytometry were performed for evaluating myeloma cytotoxicity. Western blot, immunofluorescence, immunoprecipitation, GST pull down and Electrophoretic Mobility Shift Assay were performed for protein expression and interaction between c-Myc and Max. c-Myc downstream targets were measured by Q-PCR and Chromatin immunoprecipitation methods. Animal experiments were used to detect myeloma xenograft and infiltration in vivo. We successfully identified a novel c-Myc inhibitor D347-2761, which hindered the formation of c-Myc/Max heterodimer and disturbed c-Myc protein stability simultaneously. Compound D347-2761 dose-and time-dependently inhibited myeloma cell proliferation and induced apoptosis. Dual knockout Bak/Bax partially restored D347-2761-mediated cell death. Additionally, compound D347-2761 could, in combination with bortezomib (BTZ), enhance MM cell DNA damage and overcome BTZ drug resistance. Our in vivo studies also showed that compound D347-2761 repressed myeloma growth and distal infiltration by downregulating c-Myc expression. Mechanistically, novel dual-targeting c-Myc inhibitor D347-2761 promoted c-Myc protein degradation via stimulating c-Myc Thr58 phosphorylation levels, which ultimately led to transcriptional repression of CDK4 promoter activity. We identified a novel dual-targeting c-Myc small molecular inhibitor D347-2761. And this study may provide a solid foundation for developing a novel therapeutic agent targeting c-Myc.
datePublished:2022-05-26T00:00:00Z
dateModified:2022-05-26T00:00:00Z
pageStart:1
pageEnd:16
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12964-022-00868-6
keywords:
c-Myc inhibitor
Multiple myeloma
DNA damage
Drug resistance
Apoptosis
Cell Biology
Protein-Ligand Interactions
Receptors
Cytokines and Growth Factors
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig6_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig7_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig8_HTML.png
isPartOf:
name:Cell Communication and Signaling
issn:
1478-811X
volumeNumber:20
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Ruosi Yao
affiliation:
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
name:The Affiliated Hospital of Xuzhou Medical University
address:
name:Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
name:Xuzhou Ruihu Health Management and Consulting Co., Ltd
address:
name:Xuzhou Ruihu Health Management and Consulting Co., Ltd, Xuzhou, China
type:PostalAddress
type:Organization
type:Person
name:Menghui Zhang
affiliation:
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
type:Person
name:Jian Zhou
affiliation:
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
type:Person
name:Linlin Liu
affiliation:
name:Xuzhou Medical University
address:
name:College of Medical Imaging, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yan Zhang
affiliation:
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
type:Person
name:Jian Gao
affiliation:
name:Xuzhou Medical University
address:
name:Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Kailin Xu
url:http://orcid.org/0000-0003-1375-1084
affiliation:
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
name:The Affiliated Hospital of Xuzhou Medical University
address:
name:Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Novel dual-targeting c-Myc inhibitor D347-2761 represses myeloma growth via blocking c-Myc/Max heterodimerization and disturbing its stability
description:Transcription factor c-Myc plays a critical role in various physiological and pathological events. c-Myc gene rearrangement is closely associated with multiple myeloma (MM) progression and drug resistance. Thereby, targeting c-Myc is expected to be a useful therapeutic strategy for hematological disease, especially in MM.
Molecular docking-based virtual screening and dual-luciferase reporter gene assay were used to identify novel c-Myc inhibitors. Cell viability and flow cytometry were performed for evaluating myeloma cytotoxicity. Western blot, immunofluorescence, immunoprecipitation, GST pull down and Electrophoretic Mobility Shift Assay were performed for protein expression and interaction between c-Myc and Max. c-Myc downstream targets were measured by Q-PCR and Chromatin immunoprecipitation methods. Animal experiments were used to detect myeloma xenograft and infiltration in vivo. We successfully identified a novel c-Myc inhibitor D347-2761, which hindered the formation of c-Myc/Max heterodimer and disturbed c-Myc protein stability simultaneously. Compound D347-2761 dose-and time-dependently inhibited myeloma cell proliferation and induced apoptosis. Dual knockout Bak/Bax partially restored D347-2761-mediated cell death. Additionally, compound D347-2761 could, in combination with bortezomib (BTZ), enhance MM cell DNA damage and overcome BTZ drug resistance. Our in vivo studies also showed that compound D347-2761 repressed myeloma growth and distal infiltration by downregulating c-Myc expression. Mechanistically, novel dual-targeting c-Myc inhibitor D347-2761 promoted c-Myc protein degradation via stimulating c-Myc Thr58 phosphorylation levels, which ultimately led to transcriptional repression of CDK4 promoter activity. We identified a novel dual-targeting c-Myc small molecular inhibitor D347-2761. And this study may provide a solid foundation for developing a novel therapeutic agent targeting c-Myc.
datePublished:2022-05-26T00:00:00Z
dateModified:2022-05-26T00:00:00Z
pageStart:1
pageEnd:16
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12964-022-00868-6
keywords:
c-Myc inhibitor
Multiple myeloma
DNA damage
Drug resistance
Apoptosis
Cell Biology
Protein-Ligand Interactions
Receptors
Cytokines and Growth Factors
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig6_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig7_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_Fig8_HTML.png
isPartOf:
name:Cell Communication and Signaling
issn:
1478-811X
volumeNumber:20
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Ruosi Yao
affiliation:
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
name:The Affiliated Hospital of Xuzhou Medical University
address:
name:Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
name:Xuzhou Ruihu Health Management and Consulting Co., Ltd
address:
name:Xuzhou Ruihu Health Management and Consulting Co., Ltd, Xuzhou, China
type:PostalAddress
type:Organization
type:Person
name:Menghui Zhang
affiliation:
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
type:Person
name:Jian Zhou
affiliation:
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
type:Person
name:Linlin Liu
affiliation:
name:Xuzhou Medical University
address:
name:College of Medical Imaging, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yan Zhang
affiliation:
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
type:Person
name:Jian Gao
affiliation:
name:Xuzhou Medical University
address:
name:Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Kailin Xu
url:http://orcid.org/0000-0003-1375-1084
affiliation:
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
name:The Affiliated Hospital of Xuzhou Medical University
address:
name:Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Cell Communication and Signaling
issn:
1478-811X
volumeNumber:20
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
name:The Affiliated Hospital of Xuzhou Medical University
address:
name:Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
type:PostalAddress
name:Xuzhou Ruihu Health Management and Consulting Co., Ltd
address:
name:Xuzhou Ruihu Health Management and Consulting Co., Ltd, Xuzhou, China
type:PostalAddress
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
name:Xuzhou Medical University
address:
name:College of Medical Imaging, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
name:Xuzhou Medical University
address:
name:Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
name:The Affiliated Hospital of Xuzhou Medical University
address:
name:Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Ruosi Yao
affiliation:
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
name:The Affiliated Hospital of Xuzhou Medical University
address:
name:Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
name:Xuzhou Ruihu Health Management and Consulting Co., Ltd
address:
name:Xuzhou Ruihu Health Management and Consulting Co., Ltd, Xuzhou, China
type:PostalAddress
type:Organization
name:Menghui Zhang
affiliation:
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
name:Jian Zhou
affiliation:
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
name:Linlin Liu
affiliation:
name:Xuzhou Medical University
address:
name:College of Medical Imaging, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
name:Yan Zhang
affiliation:
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
name:Jian Gao
affiliation:
name:Xuzhou Medical University
address:
name:Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
email:[email protected]
name:Kailin Xu
url:http://orcid.org/0000-0003-1375-1084
affiliation:
name:Xuzhou Medical University
address:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
name:The Affiliated Hospital of Xuzhou Medical University
address:
name:Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
name:Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
name:Xuzhou Ruihu Health Management and Consulting Co., Ltd, Xuzhou, China
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
name:College of Medical Imaging, Xuzhou Medical University, Xuzhou, China
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
name:Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China
name:Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
name:Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
External Links {๐}(128)
- Get to know what's the income of https://www.springernature.com/gp/authors
- What are the total earnings of https://link.springernature.com/home/?
- What's the financial gain of https://order.springer.com/public/cart?
- What is the monthly revenue of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- Financial intake of https://biosignaling.biomedcentral.com/about
- What's the income of https://submission.nature.com/new-submission/12964/3?
- Profit of https://orcid.org/0000-0003-1375-1084
- Get to know what's the income of https://doi.org/10.1038%2Fsj.onc.1202746
- How much profit does http://scholar.google.com/scholar_lookup?&title=MYC%20oncogenes%20and%20human%20neoplastic%20disease&journal=Oncogene&doi=10.1038%2Fsj.onc.1202746&volume=18&pages=3004-3016&publication_year=1999&author=Nesbit%2CCE&author=Tersak%2CJM&author=Prochownik%2CEV generate?
- What's the financial intake of https://doi.org/10.1016%2Fj.bcmd.2010.08.002?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20impact%20of%20MYC%20expression%20in%20lymphoma%20biology%3A%20beyond%20Burkitt%20lymphoma&journal=Blood%20Cells%20Mol%20Dis&doi=10.1016%2Fj.bcmd.2010.08.002&volume=45&pages=317-323&publication_year=2010&author=Smith%2CSM&author=Anastasi%2CJ&author=Cohen%2CKS&author=Godley%2CLA net monthly?
- What's the profit of https://doi.org/10.1080%2F10428194.2016.1187275?
- How much does http://scholar.google.com/scholar_lookup?&title=Overexpression%20of%20c-myc%20is%20associated%20with%20adverse%20clinical%20features%20and%20worse%20overall%20survival%20in%20multiple%20myeloma&journal=Leuk%20Lymphoma&doi=10.1080%2F10428194.2016.1187275&volume=57&pages=2526-2534&publication_year=2016&author=Szabo%2CAG&author=Gang%2CAO&author=Pedersen%2CMO&author=Poulsen%2CTS&author=Klausen%2CTW&author=Norgaard%2CP make?
- How much does https://doi.org/10.15252%2Fembr.201642067 pull in monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=LncRNA-MIF%2C%20a%20c-Myc-activated%20long%20non-coding%20RNA%2C%20suppresses%20glycolysis%20by%20promoting%20Fbxw7-mediated%20c-Myc%20degradation&journal=EMBO%20Rep&doi=10.15252%2Fembr.201642067&volume=17&pages=1204-1220&publication_year=2016&author=Zhang%2CP&author=Cao%2CL&author=Fan%2CP&author=Mei%2CY&author=Wu%2CM earn?
- How much does https://doi.org/10.1038%2Fs41467-019-11447-8 net monthly?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=LncRNA%20GLCC1%20promotes%20colorectal%20carcinogenesis%20and%20glucose%20metabolism%20by%20stabilizing%20c-Myc&journal=Nat%20Commun&doi=10.1038%2Fs41467-019-11447-8&volume=10&publication_year=2019&author=Tang%2CJ&author=Yan%2CT&author=Bao%2CY&author=Shen%2CC&author=Yu%2CC&author=Zhu%2CX?
- How much does https://doi.org/10.1182%2Fblood-2011-08-371567 pull in monthly?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Addiction%20to%20c-MYC%20in%20multiple%20myeloma&journal=Blood&doi=10.1182%2Fblood-2011-08-371567&volume=120&pages=2450-2453&publication_year=2012&author=Holien%2CT&author=Vatsveen%2CTK&author=Hella%2CH&author=Waage%2CA&author=Sundan%2CA
- https://doi.org/10.1038%2Fleu.2011.53's financial summary
- How much does http://scholar.google.com/scholar_lookup?&title=Clinical%20and%20biological%20implications%20of%20MYC%20activation%3A%20a%20common%20difference%20between%20MGUS%20and%20newly%20diagnosed%20multiple%20myeloma&journal=Leukemia&doi=10.1038%2Fleu.2011.53&volume=25&pages=1026-1035&publication_year=2011&author=Chng%2CWJ&author=Huang%2CGF&author=Chung%2CTH&author=Ng%2CSB&author=Gonzalez-Paz%2CN&author=Troska-Price%2CT make?
- How much profit does https://doi.org/10.18632%2Foncotarget.631 make?
- How much income does http://scholar.google.com/scholar_lookup?&title=Oncogene%20addiction%20to%20c-MYC%20in%20myeloma%20cells&journal=Oncotarget&doi=10.18632%2Foncotarget.631&volume=3&pages=739-740&publication_year=2012&author=Holien%2CT&author=Sundan%2CA have?
- How much income does https://doi.org/10.1016%2Fj.cell.2011.08.017 have?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=BET%20bromodomain%20inhibition%20as%20a%20therapeutic%20strategy%20to%20target%20c-Myc&journal=Cell&doi=10.1016%2Fj.cell.2011.08.017&volume=146&pages=904-917&publication_year=2011&author=Delmore%2CJE&author=Issa%2CGC&author=Lemieux%2CME&author=Rahl%2CPB&author=Shi%2CJ&author=Jacobs%2CHM generate?
- How much profit is https://doi.org/10.1038%2Fsj.leu.2404317 making per month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Aberrant%20stabilization%20of%20c-Myc%20protein%20in%20some%20lymphoblastic%20leukemias&journal=Leukemia&doi=10.1038%2Fsj.leu.2404317&volume=20&pages=1572-1581&publication_year=2006&author=Malempati%2CS&author=Tibbitts%2CD&author=Cunningham%2CM&author=Akkari%2CY&author=Olson%2CS&author=Fan%2CG produce monthly?
- How much does https://doi.org/10.1038%2Fsj.emboj.7600217 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Phosphorylation-dependent%20degradation%20of%20c-Myc%20is%20mediated%20by%20the%20F-box%20protein%20Fbw7&journal=EMBO%20J&doi=10.1038%2Fsj.emboj.7600217&volume=23&pages=2116-2125&publication_year=2004&author=Yada%2CM&author=Hatakeyama%2CS&author=Kamura%2CT&author=Nishiyama%2CM&author=Tsunematsu%2CR&author=Imaki%2CH net monthly?
- What's the revenue for https://doi.org/10.1016%2FS1097-2765%2803%2900173-4?
- How much money does http://scholar.google.com/scholar_lookup?&title=Skp2%20regulates%20Myc%20protein%20stability%20and%20activity&journal=Mol%20Cell&doi=10.1016%2FS1097-2765%2803%2900173-4&volume=11&pages=1177-1188&publication_year=2003&author=Kim%2CSY&author=Herbst%2CA&author=Tworkowski%2CKA&author=Salghetti%2CSE&author=Tansey%2CWP make?
- What's the income generated by https://doi.org/10.1016%2Fj.molcel.2015.11.007 each month?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Ubiquitin-dependent%20turnover%20of%20MYC%20antagonizes%20MYC%2FPAF1C%20complex%20accumulation%20to%20drive%20transcriptional%20elongation&journal=Mol%20Cell&doi=10.1016%2Fj.molcel.2015.11.007&volume=61&pages=54-67&publication_year=2016&author=Jaenicke%2CLA&author=Eyss%2CB&author=Carstensen%2CA&author=Wolf%2CE&author=Xu%2CW&author=Greifenberg%2CAK each month?
- How much does https://doi.org/10.1038%2Fonc.2008.123 rake in every month?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Pim%20kinase-dependent%20inhibition%20of%20c-Myc%20degradation&journal=Oncogene&doi=10.1038%2Fonc.2008.123&volume=27&pages=4809-4819&publication_year=2008&author=Zhang%2CY&author=Wang%2CZ&author=Li%2CX&author=Magnuson%2CNS make?
- How much money does https://doi.org/10.1016%2Fj.ccell.2017.06.001 make?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Stabilization%20of%20the%20c-Myc%20protein%20by%20CAMKIIgamma%20promotes%20T%20cell%20lymphoma&journal=Cancer%20Cell&doi=10.1016%2Fj.ccell.2017.06.001&volume=32&pages=115-28.e7&publication_year=2017&author=Gu%2CY&author=Zhang%2CJ&author=Ma%2CX&author=Kim%2CBW&author=Wang%2CH&author=Li%2CJ?
- What's the financial gain of https://doi.org/10.1073%2Fpnas.0402770101?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=The%20Fbw7%20tumor%20suppressor%20regulates%20glycogen%20synthase%20kinase%203%20phosphorylation-dependent%20c-Myc%20protein%20degradation&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0402770101&volume=101&pages=9085-9090&publication_year=2004&author=Welcker%2CM&author=Orian%2CA&author=Jin%2CJ&author=Grim%2CJE&author=Harper%2CJW&author=Eisenman%2CRN?
- Explore the financials of https://doi.org/10.1038%2Fs41598-018-21189-0
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Novel%20ubiquitin-independent%20nucleolar%20c-Myc%20degradation%20pathway%20mediated%20by%20antizyme%202&journal=Sci%20Rep&doi=10.1038%2Fs41598-018-21189-0&volume=8&publication_year=2018&author=Murai%2CN&author=Murakami%2CY&author=Tajima%2CA&author=Matsufuji%2CS produce monthly?
- Financial intake of https://doi.org/10.1042%2FBSR20181027
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Identification%20of%20a%20novel%20c-Myc%20inhibitor%20with%20antitumor%20effects%20on%20multiple%20myeloma%20cells&journal=Biosci%20Rep&doi=10.1042%2FBSR20181027&volume=38&publication_year=2018&author=Yao%2CR&author=Sun%2CX&author=Xie%2CY&author=Sun%2CX&author=Yao%2CY&author=Li%2CH?
- What's the financial gain of https://doi.org/10.2147%2FDDDT.S264077?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Identification%20of%20a%20novel%20c-Myc%20inhibitor%207594%E2%80%930037%20by%20structure-based%20virtual%20screening%20and%20investigation%20of%20its%20anti-cancer%20effect%20on%20multiple%20myeloma&journal=Drug%20Des%20Dev%20Ther&doi=10.2147%2FDDDT.S264077&volume=14&pages=3983-3993&publication_year=2020&author=Yao%2CR&author=Xie%2CY&author=Sun%2CX&author=Zhang%2CM&author=Zhou%2CJ&author=Liu%2CL
- How much does https://doi.org/10.1038%2Fnature13537 rake in every month?
- How much income is http://scholar.google.com/scholar_lookup?&title=Selective%20transcriptional%20regulation%20by%20Myc%20in%20cellular%20growth%20control%20and%20lymphomagenesis&journal=Nature&doi=10.1038%2Fnature13537&volume=511&pages=488-492&publication_year=2014&author=Sabo%2CA&author=Kress%2CTR&author=Pelizzola%2CM&author=Pretis%2CS&author=Gorski%2CMM&author=Tesi%2CA earning monthly?
- How much income is https://doi.org/10.1016%2Fj.jbc.2021.100903 earning monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=A%20novel%20inhibitor%20L755507%20efficiently%20blocks%20c-Myc-MAX%20heterodimerization%20and%20induces%20apoptosis%20in%20cancer%20cells&journal=J%20Biol%20Chem&doi=10.1016%2Fj.jbc.2021.100903&volume=297&publication_year=2021&author=Singh%2CA&author=Kumar%2CA&author=Kumar%2CP&author=Nayak%2CN&author=Bhardwaj%2CT&author=Giri%2CR earn?
- What's the monthly income of https://doi.org/10.1016%2Fj.ccell.2019.10.001?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Small-molecule%20MYC%20inhibitors%20suppress%20tumor%20growth%20and%20enhance%20immunotherapy&journal=Cancer%20Cell&doi=10.1016%2Fj.ccell.2019.10.001&volume=36&pages=483-97.e15&publication_year=2019&author=Han%2CH&author=Jain%2CAD&author=Truica%2CMI&author=Izquierdo-Ferrer%2CJ&author=Anker%2CJF&author=Lysy%2CB
- How much does https://doi.org/10.1021%2Facschembio.7b00799 bring in each month?
- Get to know http://scholar.google.com/scholar_lookup?&title=Targeted%20disruption%20of%20myc-max%20oncoprotein%20complex%20by%20a%20small%20molecule&journal=ACS%20Chem%20Biol&doi=10.1021%2Facschembio.7b00799&volume=12&pages=2715-2719&publication_year=2017&author=Choi%2CSH&author=Mahankali%2CM&author=Lee%2CSJ&author=Hull%2CM&author=Petrassi%2CHM&author=Chatterjee%2CAK's earnings
- What's the profit of https://doi.org/10.1016%2FS0092-8674%2802%2901284-9?
- Get to know http://scholar.google.com/scholar_lookup?&title=X-ray%20structures%20of%20Myc-Max%20and%20Mad-Max%20recognizing%20DNA.%20Molecular%20bases%20of%20regulation%20by%20proto-oncogenic%20transcription%20factors&journal=Cell&doi=10.1016%2FS0092-8674%2802%2901284-9&volume=112&pages=193-205&publication_year=2003&author=Nair%2CSK&author=Burley%2CSK's earnings
- What's the profit of https://doi.org/10.1016%2Fj.ejmech.2018.09.023?
- How much does http://scholar.google.com/scholar_lookup?&title=Computer-aided%20drug%20discovery%20of%20Myc-Max%20inhibitors%20as%20potential%20therapeutics%20for%20prostate%20cancer&journal=Eur%20J%20Med%20Chem&doi=10.1016%2Fj.ejmech.2018.09.023&volume=160&pages=108-119&publication_year=2018&author=Carabet%2CLA&author=Lallous%2CN&author=Leblanc%2CE&author=Ban%2CF&author=Morin%2CH&author=Lawn%2CS pull in monthly?
- https://doi.org/10.3389%2Ffphar.2021.653233's revenue stream
- What's http://scholar.google.com/scholar_lookup?&title=Design%2C%20synthesis%20and%20pharmacological%20evaluation%20of%20naphthofuran%20derivatives%20as%20potent%20SIRT1%20activators&journal=Front%20Pharmacol&doi=10.3389%2Ffphar.2021.653233&volume=12&publication_year=2021&author=Gao%2CJ&author=Chen%2CQ-Q&author=Huang%2CY&author=Li%2CK-H&author=Geng%2CX-J&author=Wang%2CT's gross income?
- What's the profit of https://doi.org/10.1073%2Fpnas.0604129103?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Global%20mapping%20of%20c-Myc%20binding%20sites%20and%20target%20gene%20networks%20in%20human%20B%20cells&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0604129103&volume=103&pages=17834-17839&publication_year=2006&author=Zeller%2CKI&author=Zhao%2CX&author=Lee%2CCW&author=Chiu%2CKP&author=Yao%2CF&author=Yustein%2CJT?
- How much revenue does https://doi.org/10.3324%2Fhaematol.2008.004440 produce monthly?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Loss%20of%201p%20and%20rearrangement%20of%20MYC%20are%20associated%20with%20progression%20of%20smouldering%20myeloma%20to%20myeloma%3A%20sequential%20analysis%20of%20a%20single%20case&journal=Haematologica&doi=10.3324%2Fhaematol.2008.004440&volume=94&pages=1024-1028&publication_year=2009&author=Chiecchio%2CL&author=Dagrada%2CGP&author=Protheroe%2CRK&author=Stockley%2CDM&author=Smith%2CAG&author=Orchard%2CKH?
- Find out how much https://doi.org/10.1002%2Fgcc.20670 earns monthly
- How much profit does http://scholar.google.com/scholar_lookup?&title=Frequent%20upregulation%20of%20MYC%20in%20plasma%20cell%20leukemia&journal=Genes%20Chromosom%20Cancer&doi=10.1002%2Fgcc.20670&volume=48&pages=624-636&publication_year=2009&author=Chiecchio%2CL&author=Dagrada%2CGP&author=White%2CHE&author=Towsend%2CMR&author=Protheroe%2CRK&author=Cheung%2CKL generate?
- How much revenue does https://doi.org/10.1038%2Fnrc2231 generate?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Reflecting%20on%2025%20years%20with%20MYC&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2231&volume=8&pages=976-990&publication_year=2008&author=Meyer%2CN&author=Penn%2CLZ making per month?
- Get to know what's the income of https://doi.org/10.1016%2FS2352-3026%2816%2900021-1
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Bromodomain%20inhibitor%20OTX015%20in%20patients%20with%20lymphoma%20or%20multiple%20myeloma%3A%20a%20dose-escalation%2C%20open-label%2C%20pharmacokinetic%2C%20phase%201%20study&journal=Lancet%20Haematol&doi=10.1016%2FS2352-3026%2816%2900021-1&volume=3&pages=e196-204&publication_year=2016&author=Amorim%2CS&author=Stathis%2CA&author=Gleeson%2CM&author=Iyengar%2CS&author=Magarotto%2CV&author=Leleu%2CX?
- How much cash flow does https://doi.org/10.1021%2Facs.jmedchem.5b01882 have monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Identification%20of%20a%20benzoisoxazoloazepine%20inhibitor%20%28CPI-0610%29%20of%20the%20bromodomain%20and%20extra-terminal%20%28BET%29%20family%20as%20a%20candidate%20for%20human%20clinical%20trials&journal=J%20Med%20Chem&doi=10.1021%2Facs.jmedchem.5b01882&volume=59&pages=1330-1339&publication_year=2016&author=Albrecht%2CBK&author=Gehling%2CVS&author=Hewitt%2CMC&author=Vaswani%2CRG&author=Cote%2CA&author=Leblanc%2CY earn?
- Get to know what's the income of https://doi.org/10.1016%2Fj.trecan.2020.05.006
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Genomic%20instability%20in%20multiple%20myeloma&journal=Trends%20Cancer&doi=10.1016%2Fj.trecan.2020.05.006&volume=6&pages=858-873&publication_year=2020&author=Alagpulinsa%2CDA&author=Szalat%2CRE&author=Poznansky%2CMC&author=Shmookler%20Reis%2CRJ?
- What are the earnings of https://doi.org/10.1182%2Fblood-2007-05-089193?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Dysfunctional%20homologous%20recombination%20mediates%20genomic%20instability%20and%20progression%20in%20myeloma&journal=Blood&doi=10.1182%2Fblood-2007-05-089193&volume=113&pages=2290-2297&publication_year=2009&author=Shammas%2CMA&author=Shmookler%20Reis%2CRJ&author=Koley%2CH&author=Batchu%2CRB&author=Li%2CC&author=Munshi%2CNC?
- How much does https://doi.org/10.1038%2Fs41580-019-0152-0 gross monthly?
- Get to know http://scholar.google.com/scholar_lookup?&title=DNA%20double-strand%20break%20repair-pathway%20choice%20in%20somatic%20mammalian%20cells&journal=Nat%20Rev%20Mol%20Cell%20Biol&doi=10.1038%2Fs41580-019-0152-0&volume=20&pages=698-714&publication_year=2019&author=Scully%2CR&author=Panday%2CA&author=Elango%2CR&author=Willis%2CNA's earnings
- What's the financial outcome of https://doi.org/10.1128%2FMCB.01405-08?
- How much does http://scholar.google.com/scholar_lookup?&title=Subcellular%20localization%20of%20glycogen%20synthase%20kinase%203beta%20controls%20embryonic%20stem%20cell%20self-renewal&journal=Mol%20Cell%20Biol&doi=10.1128%2FMCB.01405-08&volume=29&pages=2092-2104&publication_year=2009&author=Bechard%2CM&author=Dalton%2CS gross monthly?
- See how much https://doi.org/10.1074%2Fjbc.R700001200 makes per month
- How much income is http://scholar.google.com/scholar_lookup?&title=The%20double%20bromodomain-containing%20chromatin%20adaptor%20Brd4%20and%20transcriptional%20regulation&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.R700001200&volume=282&pages=13141-13145&publication_year=2007&author=Wu%2CSY&author=Chiang%2CCM earning monthly?
- How much profit does https://doi.org/10.1016%2Fj.molcel.2018.09.031 make?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=MYC%20protein%20interactome%20profiling%20reveals%20functionally%20distinct%20regions%20that%20cooperate%20to%20drive%20tumorigenesis&journal=Mol%20Cell&doi=10.1016%2Fj.molcel.2018.09.031&volume=72&pages=836-48.e7&publication_year=2018&author=Kalkat%2CM&author=Resetca%2CD&author=Lourenco%2CC&author=Chan%2CPK&author=Wei%2CY&author=Shiah%2CYJ
- How much does https://doi.org/10.1073%2Fpnas.1919507117 rake in every month?
- How much money does http://scholar.google.com/scholar_lookup?&title=MYC%20protein%20stability%20is%20negatively%20regulated%20by%20BRD4&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.1919507117&volume=117&pages=13457-13467&publication_year=2020&author=Devaiah%2CBN&author=Mu%2CJ&author=Akman%2CB&author=Uppal%2CS&author=Weissman%2CJD&author=Cheng%2CD make?
- Earnings of https://doi.org/10.1073%2Fpnas.050586197
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Identification%20of%20CDK4%20as%20a%20target%20of%20c-MYC&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.050586197&volume=97&pages=2229-2234&publication_year=2000&author=Hermeking%2CH&author=Rago%2CC&author=Schuhmacher%2CM&author=Li%2CQ&author=Barrett%2CJF&author=Obaya%2CAJ each month?
- How much does https://citation-needed.springer.com/v2/references/10.1186/s12964-022-00868-6?format=refman&flavour=references net monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ruosi%20Yao net monthly?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ruosi%20Yao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Menghui%20Zhang?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Menghui%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jian%20Zhou bring in?
- Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jian%20Zhou%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Linlin%20Liu pull in monthly?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Linlin%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yan%20Zhang's financial summary
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yan%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jian%20Gao?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jian%20Gao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kailin%20Xu gross monthly?
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kailin%20Xu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Check the income stats for https://static-content.springer.com/esm/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_MOESM2_ESM.docx
- How much does https://static-content.springer.com/esm/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_MOESM3_ESM.tif make?
- https://static-content.springer.com/esm/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_MOESM4_ESM.tif's financial summary
- How much does https://static-content.springer.com/esm/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_MOESM5_ESM.tif rake in every month?
- How much does https://static-content.springer.com/esm/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_MOESM6_ESM.tif net monthly?
- How much revenue does https://static-content.springer.com/esm/art%3A10.1186%2Fs12964-022-00868-6/MediaObjects/12964_2022_868_MOESM7_ESM.docx bring in?
- How much profit does http://creativecommons.org/licenses/by/4.0/ make?
- How profitable is http://creativecommons.org/publicdomain/zero/1.0/?
- Monthly income for https://s100.copyright.com/AppDispatchServlet?title=Novel%20dual-targeting%20c-Myc%20inhibitor%20D347-2761%20represses%20myeloma%20growth%20via%20blocking%20c-Myc%2FMax%20heterodimerization%20and%20disturbing%20its%20stability&author=Ruosi%20Yao%20et%20al&contentID=10.1186%2Fs12964-022-00868-6©right=The%20Author%28s%29&publication=1478-811X&publicationDate=2022-05-26&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0
- What's the financial gain of https://crossmark.crossref.org/dialog/?doi=10.1186/s12964-022-00868-6?
- What's the monthly money flow for https://citation-needed.springer.com/v2/references/10.1186/s12964-022-00868-6?format=refman&flavour=citation?
- Learn about the earnings of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- How much income is https://www.springernature.com/gp/products earning monthly?
- How much income does https://www.springernature.com/gp/librarians have?
- How much money does https://www.springernature.com/gp/societies generate?
- Discover the revenue of https://www.springernature.com/gp/partners
- https://www.springer.com/'s financial summary
- What's the monthly income of https://www.nature.com/?
- How much does https://www.biomedcentral.com/ earn?
- How much income does https://www.palgrave.com/ have?
- Get to know https://www.apress.com/'s earnings
- How much does https://www.springernature.com/gp/legal/ccpa pull in?
- Explore the financials of https://www.springernature.com/gp/info/accessibility
- How much income is https://support.springernature.com/en/support/home earning monthly?
- What's https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations's gross income?
- Learn about the earnings of https://www.springernature.com/
Analytics and Tracking {๐}
- Google Tag Manager
Libraries {๐}
- Clipboard.js
- Prism.js
- Video.js
CDN Services {๐ฆ}
- Crossref
- Net/play">
Video Abstract